Monday , December 18 2017
Home / Resources / Clinical Presentations / Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

DCMS50_HS_Image

We continue this week with our Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents with slides on Incretins and DPP 4 Inhibitors….

Link to download (.ppt format): Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

Other sets in this series:

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5

 

Check out all of Diabetes In Control’s slide collections at our new Clinical Presentations Library.